Cuál es el precio por Mega Genomics Limited (6667)

Precio por Mega Genomics Limited (6667) es de$0.90827623

Cuál es la capitalización de mercado por Mega Genomics Limited (6667)

Capitalización de mercado por Mega Genomics Limited (6667) es $203.73M

Mega Genomics Limited (6667) Ratio P/S

Mega Genomics Limited, a genetic testing platform company, offers consumer genetic testing and cancer screening services in China. It offers brain health assessment package, a service that assesses the risk of various related diseases, including Alzheimer’s disease; alimentation capability assessment package, a service that assesses the risk of developing hyperhomocysteinemia; Parkinson’s disease risk assessment; full-scale cancer risk assessment packages; myocardial infarction and heart failure genetic testing, a service and ancillary service that assesses the genetic risk of developing myocardial infarction and heart failure; cardiovascular and cerebrovascular disease risk assessment packages; hereditary breast cancer/ovarian cancer genetic testing; Septin9 colorectal cancer screening test; RNF180/Septin9 gastric cancer screening test; cervical cancer genetic methylation testing, a cervical cancer test; telomere length genetic testing that assesses the cell age and aging rate of a person; and personal whole genome test plus, a service that assesses the risk of developing multiple types of diseases and provides interpretation for various individual traits and medication advice. It also offers whole exome sequencing package for adults, a service that assesses the risk of developing multiple high-risk diseases, hereditary cancers, recessive genetic diseases, and types of complex diseases, as well as multiple drugs, dietary nutrition items, and exercise and fitness items; folate metabolic capacity assessment testing kits to assess the risk of developing cardiovascular and cerebrovascular diseases; ApoE gene testing for testing Alzheimer’s disease; BRCA1/2 gene mutation testing kits; Alzheimer’s disease screening kits; colorectal cancer screening kits; gastric cancer screening kits; lung nodule auxiliary diagnostic kits; and cervical cancer screening kits to health checkup centers and hospitals. The company was founded in 2016 and is headquartered in Beijing, China.

Año	Ratio P/S	Cambiar
Not enough data for the provided dates.

Año

Ratio P/S

Cambiar

Not enough data for the provided dates.

Empresa	Ratio P/S	Diferencia del ratio P/S	País
HCA Healthcare, Inc. HCA.US	1.15	-	US
Fresenius SE & Co. KGaA FRE.DE	-	-	DE
Dr. Sulaiman Al Habib Medical Services Group Company 4013.SR	5.65	-	SA
Tenet Healthcare Corporation THC.US	0.98	-	US
IHH Healthcare Berhad 5225.KL	-	-	MY

Empresa

Ratio P/S

Diferencia del ratio P/S

País